Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
DURAPREP is a topical antimicrobial sponge containing iodine povacrylex and isopropyl alcohol indicated for bacterial skin antisepsis prior to surgical procedures. It combines iodine's broad-spectrum bactericidal activity with the rapid germicidal action of isopropyl alcohol. The product is designed for healthcare professionals to apply directly to the surgical site as a pre-operative skin preparation.
As an older topical antiseptic approaching loss of exclusivity in a crowded market, the brand faces declining revenue potential and likely reduced commercial team size.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
DURAPREP offers limited career mobility and growth potential as a mature, commoditized surgical antiseptic with no clinical pipeline and 0 linked job openings. Positions on this brand are typically defensive in nature, focused on maintaining institutional relationships and managing competitive share loss rather than launching innovation or expanding market reach.
Worked on DURAPREP at Solventum? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.